Xagros is a rising senior studying Biology through the College of Creative Studies at UC Santa Barbara. At UCSB, he conducts research in the Sepunaru Electrocatalysis Group, where he uses biophysical methods to study single-cell and single-molecule interactions. His research aims to elucidate the molecular interactions that drive intracellular states implicated in neurodegenerative and metabolic diseases from a physical chemistry perspective.  As an Amgen Scholar at UCLA, he is currently working in the Di Carlo Biomicrofluidics Group, developing nanovial-based platforms for single-cell antibody delivery. Nanovials are hydrogel microparticles capable of capturing single cells, enabling multiomic approaches that link transcriptional activity to secreted proteins—tools with powerful applications in immunotherapy and mapping cell–cell interaction networks. Xagros’s project focuses on engineering antibody-secreting cells inside capped nanovials to develop scalable, cell-based alternatives to gene therapy. He would like to thank Dr. Dino Di Carlo for the opportunity to pursue this work, as well as Dr. Yuta Nakagawa and PhD candidate Alyssa Arnheim for their unwavering support and mentorship. He is also deeply grateful to the Amgen Foundation for enabling this transformative experience, which has sharpened his passion for microfluidics and cell therapy and shaped his future path as an interdisciplinary researcher.